Market target layout-Novamab

Business cooperation

Looking forward to
cooperating with you

Product Out-Licensing

Product Out-Licensing

Novamab collaborates with pharmaceutical partners on advanced-stage development programs, transferring designated rights upon milestone achievements. Compensation includes predefined payments and revenue shares based on progress, with IP jointly retained per contractual terms.

Novamab collaborates with partners to co-design projects, leveraging respective expertise in implementation. Both parties jointly assume development risks and funding, with shared IP and revenue per agreement.

For inquiries regarding R&D collaboration and business cooperation, please contact Mr. Li.

ghli@novamab.com

Novamab sdAbs Collaborative Targets List

Immune Checkpoints

Anti-Angiogenesis

Tumor-Associated Targets